News

The VBCF is a proud member of the VCDI - Vienna COVID-19 Diagnostic Initiative

Read more

SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers...

Read more

In a new study published in the Journal Science Advances, the Bell lab at IMBA reveals how multiple highly-conserved chromatin modifying complexes...

Read more

Valneva has successfully completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) and agreed on the clinical development...

Read more

Valneva today provided an update on its operations as the COVID-19 situation evolves.

Read more

Read more

A marvel of complexity, the nucleus is the command center of the cell – harboring information, codes and controlled access. But different from...

Read more

Valneva announced that the Food and Drug Administration (FDA) has approved the extension of the shelf life of its Japanese encephalitis vaccine IXIARO...

Read more

The 7th Ubiquitin Symposium will be held at the Vienna BioCenter on 14-15 May 2020. The organisers have put together a program that covers various...

Read more

Austrian biotech company CALYXHA Biotechnologies GmbH announces the investment received from ARAX Capital Partners that complements the previously...

Read more

Protein Phosphatase 2 (PP2A) is an enzyme that plays important roles in regulating cell proliferation and by that has been shown to be a tumor...

Read more

The Weintraub Student Award is one of the most prestigious and competitive international student awards recognizing “outstanding achievement during...

Read more

Lyme and chikungunya passed key milestones in 2019. Significant value inflection expected in 2020 including Lyme Phase 2 data and partnering in...

Read more